186 related articles for article (PubMed ID: 29691802)
21. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
[TBL] [Abstract][Full Text] [Related]
22. Marked difference in membrane-protein-binding properties of the two isoforms of protein 4.1R expressed at early and late stages of erythroid differentiation.
Nunomura W; Parra M; Hebiguchi M; Sawada K; Mohandas N; Takakuwa Y
Biochem J; 2009 Jan; 417(1):141-8. PubMed ID: 18691159
[TBL] [Abstract][Full Text] [Related]
23. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.
Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA
Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444
[TBL] [Abstract][Full Text] [Related]
24. Phosphatidylcholine and Phosphatidylserine Uniquely Modify the Secondary Structure of α-Synuclein Oligomers Formed in Their Presence at the Early Stages of Protein Aggregation.
Dou T; Kurouski D
ACS Chem Neurosci; 2022 Aug; 13(16):2380-2385. PubMed ID: 35904551
[TBL] [Abstract][Full Text] [Related]
25. C-terminal truncation is a prominent post-translational modification of human erythrocyte α-synuclein.
Amagai R; Otomo R; Yoshioka S; Nagano H; Hashimoto N; Sakakibara R; Tanaka T; Okado-Matsumoto A
J Biochem; 2024 May; 175(6):649-658. PubMed ID: 38308089
[TBL] [Abstract][Full Text] [Related]
26. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
[TBL] [Abstract][Full Text] [Related]
27. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
[TBL] [Abstract][Full Text] [Related]
28. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
Stöckl M; Fischer P; Wanker E; Herrmann A
J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
[TBL] [Abstract][Full Text] [Related]
29. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
Benskey MJ; Perez RG; Manfredsson FP
J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
[TBL] [Abstract][Full Text] [Related]
30. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
Rekas A; Ahn KJ; Kim J; Carver JA
Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
[TBL] [Abstract][Full Text] [Related]
31. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae.
Soper JH; Roy S; Stieber A; Lee E; Wilson RB; Trojanowski JQ; Burd CG; Lee VM
Mol Biol Cell; 2008 Mar; 19(3):1093-103. PubMed ID: 18172022
[TBL] [Abstract][Full Text] [Related]
32. Lysine residues at the first and second KTKEGV repeats mediate α-Synuclein binding to membrane phospholipids.
Zarbiv Y; Simhi-Haham D; Israeli E; Elhadi SA; Grigoletto J; Sharon R
Neurobiol Dis; 2014 Oct; 70():90-8. PubMed ID: 24905915
[TBL] [Abstract][Full Text] [Related]
33. Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein.
Tsigelny IF; Bar-On P; Sharikov Y; Crews L; Hashimoto M; Miller MA; Keller SH; Platoshyn O; Yuan JX; Masliah E
FEBS J; 2007 Apr; 274(7):1862-77. PubMed ID: 17381514
[TBL] [Abstract][Full Text] [Related]
34. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
Wang X; Yu S; Li F; Feng T
Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
[TBL] [Abstract][Full Text] [Related]
35. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
[TBL] [Abstract][Full Text] [Related]
36. The nuclear accumulation of alpha-synuclein is mediated by importin alpha and promotes neurotoxicity by accelerating the cell cycle.
Ma KL; Song LK; Yuan YH; Zhang Y; Han N; Gao K; Chen NH
Neuropharmacology; 2014 Jul; 82():132-42. PubMed ID: 23973294
[TBL] [Abstract][Full Text] [Related]
37. Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells.
Kim SS; Moon KR; Choi HJ
Arch Pharm Res; 2011 May; 34(5):837-45. PubMed ID: 21656370
[TBL] [Abstract][Full Text] [Related]
38. The Molecular Mechanism of Alpha-Synuclein Dependent Regulation of Protein Phosphatase 2A Activity.
Qu J; Yan H; Zheng Y; Xue F; Zheng Y; Fang H; Chang Y; Yang H; Zhang J
Cell Physiol Biochem; 2018; 47(6):2613-2625. PubMed ID: 29996119
[TBL] [Abstract][Full Text] [Related]
39. Alpha-synuclein functions as a negative regulator for expression of tyrosine hydroxylase.
Li YH; Gao N; Ye YW; Li X; Yu S; Yang H; Uéda K; Chan P
Acta Neurol Belg; 2011 Jun; 111(2):130-5. PubMed ID: 21748932
[TBL] [Abstract][Full Text] [Related]
40. Membrane differentiation in human erythroid cells: unique profiles of cell surface glycoproteins expressed in erythroblasts in vitro from three ontogenic stages.
Fukuda M; Fukuda MN; Papayannopoulou T; Hakomori S
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3474-8. PubMed ID: 6774338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
